`

Red One™ – A New Era in Rapid Microbial Detection

In quality-critical industries like pharmaceuticals, cosmetics, and water treatment, microbial testing must balance speed, sensitivity, and regulatory compliance. Traditional culture-based methods, although proven, require several days—or even weeks—to yield results.

Enter Red One™ – the latest generation of automated solid-phase cytometry – now available in India through BiomatiQ, your trusted partner for advanced microbiological solutions.

What is Red One™?
Red One™ is a fully automated platform for detecting and enumerating viable microorganisms in filterable liquid samples, including those rendered filterable through pretreatment (e.g., rinsing or lysis). It identifies viable single cells based on their esterase activity, using a fluorescent substrate.

With applications across rapid screening, bioburden, and sterility testing, Red One™ delivers fast and highly reliable results—with no need for calibration.

Core Advantages

  • Sample Volume Range: 10 µL to 250 mL
  • Single-Use Cap: Touch-free workflow reducing risk of contaminations
  • Fully Automated: Filtration, staining and analysis – repeatable and robust procedure
  • Calibration-Free Operation – reduces hands-on time and variability
  • Compact Footprint: Integrates easily into a safety cabinet

Red One™ Applications

1. Rapid Screening in 10 Minutes
The Direct Viable Count application provides a total viable cell count in just 10 minutes. Simply drop the sample onto the disposable cap — and the system does the rest.
• Detects as low as a few cells/sample
• Superior to ATP & Flow Cytometry (typically 1000 cells/mL LOD)
• Demonstrated consistency with traditional 5 Day counts on R2A plates for water loops
• Other applications include in-process, environmental, or lot enumeration

2. Bioburden Testing in 4 Hours
Designed for total aerobic flora including bacteria, fungi, and spores. After the initial sample filtration onto the cap, a 4-hour activation step is employed to restore the metabolic activity of the cells, making it compliant with staining and detection.
• Quantitative bioburden result in just 4 hours
• Optional 24-hour enrichment step for 1 CFU sensitivity and post-analysis identification
• Primary validation in accordance with European and US Pharmacopoeias will be available starting September 2025

3. Sterility Testing in Less Than 4 Days
A true game-changer, Red One™ performs qualitative sterility testing using standard double-canister sample prep, with a time-to-result (TTR) of less than 4 days—a major improvement over traditional 14-day methods.
• Compatible with compendial workflows
• Detects individual microbial cells, eliminating the need for high biomass
• Accelerates batch release and contamination investigations
• Full primary validation is already available, and customers receive comprehensive support for rapid product-specific validation

Globally Recognized Innovation
Red One™ has earned international recognition for its innovation and design:
Most Innovative Start-up in Microbiology (2022)
– StartUs Insights Discovery Platform (out of 1,061 companies)
Best Product Design for Healthcare (2020)
– Janus de la Santé, French Institute of Design

Ready to Transform Your Microbial Testing?
Whether you're optimizing environmental monitoring, reducing time-to-release, or increasing the reliability of sterility testing—Red One™ delivers.

Contact BiomatiQ today to schedule a demo, request a technical brochure, or speak to our application specialists.
contact@biomatiq.com
Toll Free No.: 1800 571 9696